LONDON: Abingdon Health plc (AIM: ABDX), a leading international developer and manufacturer of high quality and effective rapid tests, notes the publication of data1 by the Office for National Statistics (ONS) in making significant steps forward in stratifying antibody thresholds for a better understanding of protection against SARS-CoV-2 (COVID-19) infection, supporting the case for mass antibody…